Biomea Fusion, Inc. Property, Plant and Equipment
Biomea Fusion, Inc. (BMEA) had Property, Plant and Equipment of $47.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-05
- 2026-06-30: Property, Plant and Equipment, Net $47.00K.
- 2026-03-31: Property, Plant and Equipment, Net $47.00K; Property, Plant and Equipment, Net as first filed $67.00K.
- 2025-12-31: Property, Plant and Equipment, Net $153.00K.
- 2025-09-30: Property, Plant and Equipment, Net $200.00K.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $47.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $47.00K 10-Q · filed 2026-08-05 | $67.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $153.00K 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $2.83M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $3.30M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $3.77M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $4.23M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $4.45M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $4.81M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $5.16M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $5.58M 10-Q · filed 2023-10-30 | |
| 2023-06-30 | $5.98M 10-Q · filed 2023-07-31 | |
| 2023-03-31 | $6.29M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $5.84M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $3.05M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $3.00M 10-Q · filed 2022-08-01 | |
| 2022-03-31 | $2.89M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $2.96M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $2.96M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $1.50M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $165.00K 10-Q · filed 2021-05-27 | |
| 2020-12-31 | $81.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |